Table 1.
Study | Results |
---|---|
Salvatore et al., Climacteric 2015 77 patients, menopausal |
Significant improvement in FSFI scores (14.8–27.2) 17 patients inactive; normal sex life |
Gaspar et al., Am J Cosmet Surg 2011 CO2 + PRP + PFE |
Significant reduction in sexual discomfort |
Filippini et al., Photomed Laser Surg 2017 386 patients, postmenopausal |
Effective in treating vaginal epithelium and dyspareunia due to atrophy |
Perino et al., Maturitas 2015 48 patients, postmenopausal |
Confirmed safety, efficacy, satisfaction in reducing VVA symptoms |
Pieralli et al., Arch Gynecol Obstet 2016 50 patients (41–66 years) |
VHI score: 8.9–21.6 (< 15 VVA) VAS: statistics improvement in dyspareunia 52% satisfied at 11 months |
CO2, carbon dioxide; FSFI, Female Sexual Functional Index; VAS, visual analog scale; VHI, vaginal health index; VVA, vulvovaginal atrophy